Additional risk minimization materials (ARMMs)

Non-promotional HCPs/patients educational materials are required as additional risk-minimizing measures to ensure that healthcare professionals who prescribe and use these medicines, as well as patients, are aware of and take into account the specific safety requirements. The educational materials complement the information in the Thailand package insert.

Request form for the additional risk minimization materials (ARMMs)

Please select the required materials in the required quantity.

Please note that the educational materials provided here, which have been approved by the Thai FDA, are marked with . All the educational materials provided here are only valid in this version for use in Thailand.

For all materials: BMS will send you a copy of this material via email or postal shortly.

Number of items can not be less than zero.

Opdivo® (nivolumab) Patient Information Guide - English

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Opdivo® (nivolumab) Patient Information Guide - Thai

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Opdivo® (nivolumab) Patient Alert Card - English

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Opdivo® (nivolumab) Patient Alert Card - Thai

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Brochure - English

Intended for use by healthcare professionals in conjunction with the approved Thailand package insert.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Cover letter - English

Intended for use by healthcare professionals in conjunction with the approved Thailand package insert.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Risk Awareness Form - English

Intended for use by healthcare professionals in conjunction with the approved Thailand package insert.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Acknowledgement Form

Intended for use by healthcare professionals in conjunction with the approved Thailand package insert.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Patient Agreement Form - English

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Patient Agreement Form - Thai

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Patient Card - English

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Patient Card - Thai

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Rojusna® (luspatercept) Healthcare Professionals Checklist - English

Intended for use by healthcare professionals in conjunction with the approved Thailand package insert.’

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Rojusna® (luspatercept) Patient Card (for women of childbearing potential) – Thai and English

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Yervoy® (ipilimumab) Patient Alert Card - English

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Yervoy® (ipilimumab) Patient Alert Card - Thai

Intended for dissemination by healthcare professionals to their patients or patients’ caregivers.

Order quantity:

Maximum copies limit reached

Hard copy

Soft copy

Please select checkbox

Contact details

Please fill out the form below with your contact details.

Please entered required dat

Please fill the required fields

Submission error. Please try again or contact admistrator.

Title/ Salutation * Required

Professional Registration Number * Required

First name * Required

Last name * Required

Practice / Clinic / Institution * Required

Business email * Required Enter correct format

Practice / Clinic / Institution address * Required

Postal code * Required Enter correct postal code

City * Required

Country Please select the county

I have read the Privacy notice. I consent to the collection, processing and use of my personal data in accordance with the Privacy notice; this applies in particular to information about my health. Upon receipt of these educational materials, I am made aware of the risks associated with therapy and will therefore make informed decisions to select appropriate patients who may benefit from therapy while implementing the required risk mitigation measures.

I certify to only distribute the received ARMMs to individual patients.

Americas

Argentina

Brazil

Canada

Chile

Colombia

Mexico

Peru

United States

Asia Pacific

Australia

China

India

Japan

Korea

New Zealand

Singapore

Taiwan

Thailand

Europe

Austria

Belgium

Czech Republic

Denmark

Finland

France

Germany

Greece

Hungary

Ireland

Italy

Luxembourg

Netherlands

Norway

Poland

Portugal

Romania

Spain

Sweden

Switzerland

United Kingdom

Middle East

Israel

Saudi Arabia

Turkey

United Arab Emirates

Other

Other Markets

Additional risk minimization materials (ARMMs)

Request form for the additional risk minimization materials (ARMMs)

Please select the required materials in the required quantity.

Opdivo® (nivolumab) Patient Information Guide - English

Opdivo® (nivolumab) Patient Information Guide - Thai

Opdivo® (nivolumab) Patient Alert Card - English

Opdivo® (nivolumab) Patient Alert Card - Thai

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Brochure - English

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Cover letter - English

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Risk Awareness Form - English

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Healthcare Professionals Acknowledgement Form

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Patient Agreement Form - English

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Patient Agreement Form - Thai

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Patient Card - English

Pomalyst® (pomalidomide) and Revlimid® (lenalidomide) Patient Card - Thai

Rojusna® (luspatercept) Healthcare Professionals Checklist - English

Rojusna® (luspatercept) Patient Card (for women of childbearing potential) – Thai and English

Yervoy® (ipilimumab) Patient Alert Card - English

Yervoy® (ipilimumab) Patient Alert Card - Thai

Contact details

Thank you for submitting the request.

BMS will send you a copy via email shortly - (CORRECT language to be provided by the market leads)

BMS will send you a copy of this material via postal mail.